Preterm Neonates and Feeding Intolerance Active Not Recruiting Phase 4 Trials for Cysteine (DB00151)

IndicationStatusPhase
DBCOND0163230 (Preterm Neonates and Feeding Intolerance)Active Not Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06202911Effect of Oral N-Acetyl Cysteine in Prevention of Necrotizing Enterocolitis in Preterm Neonates With Feeding IntolerancePrevention